178 related articles for article (PubMed ID: 37452988)
1. Role of metabolomic profile as a potential marker to discriminate membranous nephropathy from IgA nephropathy.
Qu Y; Wang Y; Hu Z; Su C; Qian C; Pan J; Zhu Y; Shi A
Int Urol Nephrol; 2024 Feb; 56(2):635-651. PubMed ID: 37452988
[TBL] [Abstract][Full Text] [Related]
2. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy.
Chen P; Shi SF; Qu Z; Zhao N; Xie XF; Lv JC; Liu LJ; Zhang H
Ren Fail; 2018 Nov; 40(1):213-218. PubMed ID: 29619862
[TBL] [Abstract][Full Text] [Related]
4. Clinical diagnostic performance of common laboratory indicators in primary glomerulonephritis.
Li XH; Yang WY; Wang J; Yang YW; Dai CM; Zhang B; Feng JF
Eur Rev Med Pharmacol Sci; 2022 Dec; 26(24):9079-9088. PubMed ID: 36591820
[TBL] [Abstract][Full Text] [Related]
5. Biomarker prediction for membranous nephropathy prognosis by microarray analysis.
Zhou G; Xin G; Zhang W; Zhang X
Nephrology (Carlton); 2019 May; 24(5):526-533. PubMed ID: 30084529
[TBL] [Abstract][Full Text] [Related]
6. Concurrent IgA Nephropathy and Membranous Nephropathy, Is It an Overlap Syndrome?
He JW; Cui DF; Zhou XJ; Chen P; Li Y; Zhang X; Wang YN; Gan T; Liu LJ; Shi SF; Zhu L; Hou P; Lv JC; Zhang H
Front Immunol; 2022; 13():846323. PubMed ID: 35359934
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of diagnostic models for immunoglobulin A nephropathy based on gut microbes.
Dong Y; Chen J; Zhang Y; Wang Z; Shang J; Zhao Z
Front Cell Infect Microbiol; 2022; 12():1059692. PubMed ID: 36569195
[TBL] [Abstract][Full Text] [Related]
8. A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy.
Dong R; Bai M; Zhao J; Wang D; Ning X; Sun S
Front Cell Infect Microbiol; 2020; 10():557368. PubMed ID: 33194798
[TBL] [Abstract][Full Text] [Related]
9. Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy.
Haubitz M; Wittke S; Weissinger EM; Walden M; Rupprecht HD; Floege J; Haller H; Mischak H
Kidney Int; 2005 Jun; 67(6):2313-20. PubMed ID: 15882273
[TBL] [Abstract][Full Text] [Related]
10. Comparison of prognostic, clinical, and renal histopathological characteristics of overlapping idiopathic membranous nephropathy and IgA nephropathy versus idiopathic membranous nephropathy.
Chen X; Chen Y; Shi K; Lv Y; Tong H; Zhao G; Chen C; Chen B; Li D; Lu Z
Sci Rep; 2017 Sep; 7(1):11468. PubMed ID: 28904360
[TBL] [Abstract][Full Text] [Related]
11. Peroxiredoxins as Markers of Oxidative Stress in IgA Nephropathy, Membranous Nephropathy and Lupus Nephritis.
Krata N; Foroncewicz B; Zagożdżon R; Moszczuk B; Zielenkiewicz M; Pączek L; Mucha K
Arch Immunol Ther Exp (Warsz); 2021 Dec; 70(1):3. PubMed ID: 34914001
[TBL] [Abstract][Full Text] [Related]
12. Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis.
Niu X; Zhang S; Shao C; Guo Z; Wu J; Tao J; Zheng K; Ye W; Cai G; Sun W; Li M
PeerJ; 2023; 11():e15125. PubMed ID: 37065697
[TBL] [Abstract][Full Text] [Related]
13. Metabolomics study reveals blood biomarkers for early diagnosis of chronic kidney disease and IgA nephropathy: A retrospective cross-sectional study.
Fu X; Luo ZX; Yin HH; Liu YN; Du XG; Cheng W; Liu JY
Clin Chim Acta; 2024 Mar; 555():117815. PubMed ID: 38309556
[TBL] [Abstract][Full Text] [Related]
14. Altered serum metabolic profile in patients with IgA nephropathy.
Dong L; Tan J; Zhong Z; Tang Y; Qin W
Clin Chim Acta; 2023 Sep; 549():117561. PubMed ID: 37722576
[TBL] [Abstract][Full Text] [Related]
15. Coexisting Membranous Nephropathy and IgA Nephropathy.
Nishida M; Kato R; Hamaoka K
Fetal Pediatr Pathol; 2015; 34(6):351-4. PubMed ID: 26418809
[TBL] [Abstract][Full Text] [Related]
16. A non-invasive diagnostic model of immunoglobulin A nephropathy and serological markers for evaluating disease severity.
Han QX; Wang Y; Zhu HY; Zhang D; Gao J; Liu ZS; Cai GY; Chen XM
Chin Med J (Engl); 2019 Mar; 132(6):647-652. PubMed ID: 30855344
[TBL] [Abstract][Full Text] [Related]
17. The role of dendrin in IgA nephropathy.
Levin A; Schwarz A; Hulkko J; He L; Sun Y; Barany P; Bruchfeld A; Herthelius M; Wennberg L; Ebefors K; Patrakka J; Betsholtz C; Nyström J; Mölne J; Hultenby K; Witasp A; Wernerson A
Nephrol Dial Transplant; 2023 Feb; 38(2):311-321. PubMed ID: 35767852
[TBL] [Abstract][Full Text] [Related]
18. Serum and urine metabolomic biomarkers for predicting prognosis in patients with immunoglobulin A nephropathy.
Jeon YH; Lee S; Kim DW; Kim S; Bae SS; Han M; Seong EY; Song SH
Kidney Res Clin Pract; 2023 Sep; 42(5):591-605. PubMed ID: 37448290
[TBL] [Abstract][Full Text] [Related]
19. Serum complement factor B is associated with disease activity and progression of idiopathic membranous nephropathy concomitant with IgA nephropathy.
Ji FP; Wen L; Zhang YP; Liu EP; Wen JG
Int Urol Nephrol; 2022 Jun; 54(6):1287-1294. PubMed ID: 34585312
[TBL] [Abstract][Full Text] [Related]
20. Urinary sediment microRNAs can be used as potential noninvasive biomarkers for diagnosis, reflecting the severity and prognosis of diabetic nephropathy.
Han Q; Zhang Y; Jiao T; Li Q; Ding X; Zhang D; Cai G; Zhu H
Nutr Diabetes; 2021 Jun; 11(1):24. PubMed ID: 34193814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
